Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 880 | -1,031,559 | 175,065 | 528,448 | 106,176 |
| Depreciation Amortization | 2,011 | 1,575 | 1,418 | 1,523 | 3,564 |
| Income taxes - deferred | 68,090 | 72,637 | 65,739 | -333,294 | N/A |
| Accounts receivable | 47,236 | 924 | 7,993 | 7,712 | 4,091 |
| Other Working Capital | 739 | 11,279 | 2,820 | 17,731 | -941 |
| Other Operating Activity | -15,407 | 1,128,571 | 20,728 | 39,775 | 55,946 |
| Operating Cash Flow | $103,549 | $183,427 | $273,763 | $261,895 | $168,836 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -142 | -273 | -136 | -265 | -1,842 |
| Net Acquisitions | N/A | -1,026,045 | N/A | N/A | N/A |
| Investing Cash Flow | $-142 | $-1,026,318 | $-136 | $-265 | $-1,842 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 150,000 | 400,000 | N/A | N/A | N/A |
| Debt Repayment | -265,000 | -100,000 | -120,699 | N/A | N/A |
| Common Stock Issued | 11,013 | 6,357 | 9,540 | 19,581 | 18,546 |
| Common Stock Repurchased | N/A | -26,311 | -126,394 | -24,131 | N/A |
| Other Financing Activity | -2,983 | -2,886 | 0 | 0 | 0 |
| Financing Cash Flow | $-106,970 | $277,160 | $-237,553 | $-4,550 | $18,546 |
| Exchange Rate Effect | -32 | -53 | N/A | N/A | N/A |
| Beginning Cash Position | 92,154 | 657,938 | 621,864 | 364,784 | 179,244 |
| End Cash Position | 88,559 | 92,154 | 657,938 | 621,864 | 364,784 |
| Net Cash Flow | $-3,595 | $-565,784 | $36,074 | $257,080 | $185,540 |
| Free Cash Flow | |||||
| Operating Cash Flow | 103,549 | 183,427 | 273,763 | 261,895 | 168,836 |
| Capital Expenditure | -142 | -273 | -136 | -265 | -1,842 |
| Free Cash Flow | 103,407 | 183,154 | 273,627 | 261,630 | 166,994 |